Lin, M., Huang, J., Jiang, X., Zhang, J., Yu, H., Ye, J., & Zhang, D. (2016). A combination hepatoma-targeted therapy based on nanotechnology: PHRE-Egr1-HSV-TK/(131)I-antiAFPMcAb-GCV/MFH. Sci Rep.
Citação norma ChicagoLin, Mei, Junxing Huang, Xingmao Jiang, Jia Zhang, Hong Yu, Jun Ye, e Dongsheng Zhang. "A Combination Hepatoma-targeted Therapy Based On Nanotechnology: PHRE-Egr1-HSV-TK/(131)I-antiAFPMcAb-GCV/MFH." Sci Rep 2016.
Citação norma MLALin, Mei, et al. "A Combination Hepatoma-targeted Therapy Based On Nanotechnology: PHRE-Egr1-HSV-TK/(131)I-antiAFPMcAb-GCV/MFH." Sci Rep 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.